NEWARK, Del, June 01, 2022 (GLOBE NEWSWIRE) -- The global antidiabetics market is estimated to secure US$ 223 Billion while expanding at a CAGR of 9.6% during the forecast period. The growth of the market can be attributed to the increasing prevalence of diabetes across the globe. Also, the aging baby boomer is another factor driving the market in the forecast period.
According to International Diabetes Federation, the global diabetes incidence is anticipated to increase from 366 million in 2011 to 552 million by 2030. Such a significant increment in the number of diabetic patients is projected to benefit the industry in the forecast period.
Also, the development of new products is anticipated to benefit the market in the coming time. . For instance, in January 2022, Novo Nordisk, the Danish drug provider, announced the launch of oral semaglutide in India for the treatment of Type 2 diabetes. Moreover, the development of advanced pumps based on smart technologies such as; AI and ML are predicted to offer various opportunities.
For instance, in July 2021, Ypsomed AG expanded the range of features of the mylife YpsoPump system. The app-based deployment of the Dexcom G6 Continuous Glucose Monitoring (CGM) System allows people with diabetes to manage their therapy through their smartphones.
On the contrary, expenses associated with insulin pumps, lack of awareness about the treatment methods, and poor reimbursement framework in developing countries are anticipated to hinder the market growth.
Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14855
Key Takeaways from the Market Study:
· The insulin segment to record a CAGR of 9.4% by 2032
· The oral segment to witness a CAGR of 9.5% during the forecast period
· Market in the U.S to value US$ 79.6 Billion by 2032
· The U.K market to hold a value of US$ 9.2 Billion
· Japan to exhibit a CAGR of 7.9% during the forecast period
· China to secure a market value of US$ 16 Billion by 2032
“Increasing incidences of diabetic patients across the globe and the rising geriatric population are projected to play a vital role in driving the market. Moreover, ongoing R&D is another factor that will benefit the market in the forthcoming period,” says an FMI analyst.
Ask an Analyst @ https://www.futuremarketinsights.com/askus/rep-gb-14855
Competition Analysis
Key players in the region include Bayer Corporation, AstraZeneca, Boehringer Ingelheim, Eli Lilly, and Bristol-Myers Squibb. Recent key developments in the industry are:
· In May 2021, F. Hoffmann-La Roche Ltd., launched mySugar Pump Control under the mySugr app. mySugr Pump Control enables patients to control insulin pumps via smartphone to import and view the data status.
· In May 2022, the Food and Drug Administration approved a new drug for people with Type 2 diabetes. The drug, Tirzepatide is a once-a-week injection that helps people in managing their blood glucose levels and lessen food intake
Key Segments Profiled in the Global Antidiabetics Market Study
Antidiabetics Market by Product:
- Insulin-based Antidiabetics
- Rapid-Acting Analog
- Long-Acting Analog
- Premixed Insulin
- Short-Acting Analog
- Intermediate-Acting Insulin
- Antidiabetics Drug Class
- Alpha-Glucosidases Inhibitors
- Biguanides
- Sulphonylureas
- GLP-1 (Glucagon-like peptide) Agonists
- DPP-IV (Dipeptidyl Peptidase) Inhibitors
- Meglitinides
- SGLT-II (Sodium-Glucose Transport Proteins) Inhibitors
- Thiazolidinedione
Antidiabetics Market by Patient Population:
- Antidiabetics for Pediatrics
- Antidiabetics for Adults
- Antidiabetics for Geriatrics
Antidiabetics Market by Route of Administration:
- Antidiabetics Administration through Insulin Syringes/ Insulin Pens
- Antidiabetics Administration through Insulin Pumps
- Intravenous Antidiabetics Infusion
- Oral Antidiabetics Administration
- Other Routes of Antidiabetics Administration
Antidiabetics Market by Region:
- North America Antidiabetics Market
- Europe Antidiabetics Market
- APAC Antidiabetics Market
- MEA Antidiabetics Market
- Latin America Antidiabetics Market
Report Customization available @ https://www.futuremarketinsights.com/customization-available/rep-gb-14855
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. FMI Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Antidiabetics
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Mn)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
TOC Continued…
Explore FMI’s Extensive ongoing Coverage on Healthcare
Foot And Ankle Devices Market - The foot and ankle devices market is predicted to register a CAGR of 5.9% during the forecast period (2022 - 2032).
Clinical Chemistry Analyzers Market - In 2022, the global clinical chemistry analyzers market is likely to hold a value of US$ 13.6 Billion. With a CAGR of 4.8%, the market is projected at US$ 21.7 Billion during the forecast period from 2022 to 2032.
Liposuction Market - The global liposuction market is expected to witness growth at 6.8% CAGR from 2022 to 2032, with an estimated market value of around US$ 9.1 Bn as of 2032.
Breast Lesion Localization Market - The breast lesion localization market is expected to strengthen its hold on the global market at an average CAGR of 4.1% between 2022 and 2032.
Attenuated Vaccines Market - The attenuated vaccines market is anticipated to reflect a 6.8% forecast CAGR during the period of 2022-2032.
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of the Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favour the market growth in various segments based on Source, Application, Sales Channel and End-Use over the next 10-years.
Contact:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
Report: https://www.futuremarketinsights.com/reports/antidiabetics-market
LinkedIn| Twitter| Blogs
